Assessment of the addictive potential of continine anatabine and mysomine in rodents.

Ended Awarded Last action

Contract number
HHSF22301002T
Awardee
Awarding agency
Obligated
$1,589,296

Award facts

Contract value 100% obligated
$1,589,295.98 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541711 Research and Development in Biotechnology
PSC
B504 Special Studies/Analysis- Chemical/Biological
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Durham, NC 27709, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $1,589,296

Quick answers

Who was awarded contract HHSF22301002T?

HHSF22301002T was awarded to Research Triangle Institute by Food and Drug Administration (Department of Health and Human Services) on August 4, 2014.

How much is contract HHSF22301002T worth?

The government has obligated $1,589,296 on HHSF22301002T.

Is contract HHSF22301002T an order under another contract?

Yes. HHSF22301002T is a delivery order under HHSF223201310034I, an indefinite delivery contract, on FDA Tobacco Assessment Study 2013-2016.

Was contract HHSF22301002T competed?

The extent of competition for HHSF22301002T was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award